Background-The incremental prognostic value of myocardial perfusion-gated single photon emission computed tomography (MPGS) compared with exercise test has not yet been properly evaluated. Methods and Results-Five thousand six hundred seventy-two consecutive patients with known or suspected coronary disease undergoing exercise MPGS between 1997 and 2007 were included. Three-year predictive models for total death and death from cardiovascular causes or acute myocardial infarction (ie, major cardiovascular events [MCE]) were built using Cox-regression modeling, including only the clinical information. Then the exercise and MPGS information was sequentially added. The added discriminative ability of exercise test information and MPGS was assessed by net reclassification improvement and integrated discrimination improvement. The increase in predictive ability of exercise information for death and MCE was high as assessed by net reclassification improvement (0.199 and 0.263) and integrated discrimination improvement (0.042 and 0.021). The only variable of MPGS associated with total death was ejection fraction (hazard ratio, 0.84; 95% confidence interval, 0.79-0.89; P<0.001). Global stress ischemic score emerged as an additional variable associated with MCE (hazard ratio, 1.07; 95% confidence interval, 1.02-1.12; P=0.007). Adding MPGS information barely improved the prognostic value for total death (net reclassification improvement, 0.017; integrated discrimination improvement, 0.013), but it increased for MCE (net reclassification improvement, 0.122; integrated discrimination improvement, 0.033). Conclusions-Adding MPGS information to exercise information does not improve prediction of total death, although it allows a more accurate prediction of MCE. (Circ Cardiovasc Imaging. 2013;6:531-541.) The online-only Data Supplement is available at http://circimaging.ahajournals.org/lookup/suppl/
A goal of risk assessment is the identification of patients at risk for subsequent major events to enhance specific care strategies. 1, 2 In this sense, exercise test and imaging have shown an incremental value beyond clinical data for prognostic purposes. [3] [4] [5] [6] 
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Although exercise capacity based on metabolic equivalents (METS) is an excellent predictor of all-cause mortality, 7, 8 stress imaging yields incremental prognostic information. [9] [10] [11] [12] However, studies assessing the added predictive value of stress imaging may have limitations. First, the information from stress test used in some of these studies is incomplete. 10, 13 And second, in the majority of them, the definition of the incremental prognostic value of imaging has been based on the statistically significant gain. 9, 11, 12 Rather, the methodology based on eventspecific reclassification tables may better serve clinicians to assess the prognostic implications of imaging, and it offers incremental information over the C-statistic. 14 Although several studies have analyzed the incremental prognostic value of exercise test and stress imaging based on the increase of correct classifications, 2, [15] [16] [17] [18] to our knowledge no study has used the rates net reclassification improvement (NRI) and integrated discrimination improvement (IDI) to assess quantitatively the change in prognostic value when sequentially incorporating both studies.
Recent data suggest that noninvasive imaging, such as myocardial perfusion-gated single photon emission computed tomography (MPGS), has limited impact on clinical management, at least in patients without previous coronary artery disease, 19 thus questioning the use that physicians give information on MPGS. Given that MPGS does not seem to guide the clinicians approach to the patient, we wondered whether its predictive ability based on event-specific reclassification tables compared with exercise testing actually justifies its widespread uses for prediction purposes.
The aim of this study was to assess the added predictive ability of exercise test information compared with the clinical information and MPGS information compared with the clinical plus exercise test information on medium-term total mortality and major cardiovascular events (MCE; ie, cardiovascular mortality or acute myocardial infarction) based on the NRI and the IDI.
Methods

Study Patients
The study population was identified from the database of the Nuclear Cardiology Laboratory of our institution. Eight thousand nine hundred forty-seven patients underwent MPGS between 1997 and 2007, but only those patients who were able to undergo exercise (n=6616) were considered. Seven hundred seventy patients were excluded because of structural heart disease (ie, valvular heart disease and cardiomyopathies, such as hypertrophic obstructive, restrictive, or dilated), atrial fibrillation, left bundle-branch block, or pacemaker; thus, the final study sample consisted of 5672 patients with complete valid data ( Figure 1 ). For each participant, clinical information (age, sex, cardiovascular risk factors, myocardial infarction history, prior revascularizations, and drug therapies) was recorded. Three thousand five hundred ninety-seven of 5672 patients (63.4%) were on antianginal medication at the moment of the study. Patients undergoing early (<60 days after MPGS) revascularization were censored from survival analyses.
Exercise MPGS Protocol
All patients underwent standard symptom-limited cycle ergometer (n=2439) or treadmill testing (n=3233) using standard protocols with a 12-lead recording and continuous monitoring. Of these patients, 941 (16.6%) were given intravenous dipyridamole during exercise because they failed to attain 80% of maximum heart rate (HR) in the absence of symptoms or ST-segment depression. 20 Exercise duration, peak oxygen consumption estimated on METS, HR at baseline and peak exercise, HR percentage reached over expected, systolic blood pressure at baseline and peak exercise, magnitude of horizontal or downsloping ST-segment depression, and angina were recorded.
For stress-rest studies, a 1-day protocol was used with 99m Tctetrofosmin. A first dose of 370 mBq, given 30 to 60 seconds before finishing exercise, and a second dose of 900 mBq, administered at rest, were separated by an interval >45 minutes. A 2 separateday protocol was used in patients with body mass index >25, with the same dose (900 mBq) for stress and rest studies. The equipment used was a Siemens E-CAM dual-head 90° gamma camera with a high-resolution collimator and 180° semicircular orbit set in step-and-shoot mode, initiated at 45° right anterior oblique, with images of 25 seconds/frame every 3° with 64×64 matrix. Images were acquired 30 to 60 minutes after dose administration and synchronizing with ECG R wave (8 frames/cardiac cycle). Slices were reconstructed using filtered back-projection Butterworth filter (order 10, cutoff frequency 0.4). No corrections were made for attenuation and scatter.
Visual interpretation of stress and rest tomographic images was always performed side by side by 2 experienced nuclear cardiologists. To quantify perfusion, the left ventricle was divided into 5 regions (anterior, septal, apical, lateral, and inferior). A scintigraphic perfusion score ranging from 0 to 4 was assigned to each region in both stress and rest (0=normal perfusion, 1=mild hypoperfusion, 2=moderate hypoperfusion, 3=severe hypoperfusion, and 4=no uptake). Thus a patient's score could range from 0 points (normal perfusion in the 5 regions) to 20 points in case of no uptake in the 5 regions. It should be noted, regarding the interpretation of this scoring system, that the necrotic areas have different score punctuation from that of the ischemic areas; therefore, total score does not have a linear relationship with the extension of the affected areas. Summed stress score, summed rest score, and summed difference score were then calculated. Finally, it has to be noted that the perfusion images were scored before the publication of standard American Society of Nuclear Cardiology scoring methods. 21 Calculation of ejection fraction and ventricular volumes was automatically performed during rest-gated single photon emission computed tomography. Endocardial and epicardial boundaries were automatically traced using the quantitative QGS software (Cedars-Sinai Medical Center, Los Angeles, CA). 22
Outcomes
Three-year death from all causes, death from cardiovascular reasons (International Classification of Diseases, Tenth Revision [ICD]-10 codes I00 to I99), and rehospitalizations for acute myocardial infarction (ICD-I21, I22) were identified with the use of the Catalan Cause of Death Register after obtaining the corresponding permissions.
Statistical Analysis
Continuous data are presented as means and first and third quartiles (Q1-Q3) and discrete data as n and percentage. The bivariate relationships of clinical, exercise test variables, and MPGS variables to total mortality and MCE were explored by hazard ratios from unadjusted Cox-proportional hazards regression models.
To investigate the predictive ability of the clinical information, exercise test information, and MPGS on total mortality and MCE, we used Cox-regression modeling. We built 3 predictive models for total mortality and MCE: a model incorporating only clinical information, a model incorporating exercise test information into the clinical model, and a model incorporating the MPGS information into the clinical model plus exercise test model (global saturated model).
First, we built a model from clinical information using forward and backward stepwise methods, with a threshold for exit set at P>0.20 and for enter at P<0.10. We retained variables with P<0.05. Discrimination was evaluated by C-statistic. Then, to build the clinical plus exercise test model, we first incorporated into the clinical model each one of the exercise test variables one by one (see Appendix in the online-only Data Supplement). We retained the exercise test variable that was statistically associated with the outcome of interest (P<0.05) and that maximized the NRI and the IDI. 14 We repeated the process with the rest of exercise test variables. The process concluded when no exercise test variable remained statistically associated with the outcome. In a third step, we assessed the added predictive ability of the MPGS information compared with the clinical plus exercise test information following the same process. The MPGS variables that we considered as candidates to enter into the model were ejection fraction, global perfusion ischemic score, number of territories worsening at peak exercise, and worsening of the anterior, inferior, and lateral territory at peak exercise. The contribution of each individual variable for the improvement models can be found in the online-only Data Supplement ( Table I in 24 Finally, we repeated all the process estimating NRI and IDI by bootstrapping and following the recommendations for computing NRI and IDI for survival data [25] [26] [27] (Tables II and III Table 1 shows clinical, exercise test, and MPGS variables for the total population and their association with outcomes. The mean duration of the follow-up was 34.18 months (SD, 7.53; 95% confidence interval, 34-34.37 months; median, 36 months; Q1 and Q3, 36 months). In total, 96.4% patients had a minimal duration of 3 years. Two hundred seventy-six of 5672 patients died and 150 patients had an MCE (105 cardiovascular deaths and 52 myocardial infarctions) during the 3-year follow-up. Several demographic and cardiovascular risk factors were associated with the outcomes of interest. Exercise capacity based on METS, HR, and systolic blood pressure difference was associated with both total mortality and MCE, whereas maximum ST-segment depression was only related to MCE. Ejection fraction and ventricular volumes were associated with both end points. Overall, higher ischemic perfusion scores identified patients with an end point, as was the case with the number of territories worsening at peak exercise. Table 2 shows the global saturated models for both end points. Age, sex, diabetes mellitus, prior acute myocardial infarction, and nitrate therapy predicted both total death and MCE, whereas prior revascularization was associated only with the former. Exercise capacity based on METS and HR difference predicted both end points, whereas maximum STsegment depression predicted only MCE. Concerning the MPGS information, ejection fraction was associated with both end points, whereas ischemia perfusion score at stress also predicted MCE.
Results
Multivariable Analysis
Discrimination
The C-statistic increased significantly for mortality prediction when exercise test information was incorporated into the clinical model (C-statistic increase, 0.05; P<0.001), but this was not the case when MPGS information was included into the clinical plus exercise test model (C-statistic increase, 0.009; P=0.113; Figure 2A ). For MCE prediction, the increase in C-statistic was significant when both exercise test and MPGS information was sequentially incorporated into the model, although the magnitude of the increase was greater when incorporating exercise test information: 0.055 (P<0.001) and 0.032 (P=0.006), respectively ( Figure 2B) . Tables 3 through 6 show reclassification for people who experienced an event and those who did not, across 3 strata risks and using sequential models, for total death and MCE, respectively. Figure 3 summarizes the global reclassification rates. Total death reclassification using exercise test information was more accurate in 35 (12.7%) and less accurate in 21 (7.6%) subjects who died, thus accounting for a net improvement of 5.1% subjects better reclassified using exercise test (Table 3 and Figure 3A ). The respective rates in people who did not die were 24.1% and 9.2% (net improvement of 14.9%). When incorporating MPGS information (Table 4 ), the saturated model did not improve but worsened the reclassification of people who died (net improvement, −1.4%) and barely improved the reclassification of people without event (net improvement, 2.7%). Overall, the NRIs and IDIs for predicting total death using clinical plus exercise test were 0.2 and 0.042, respectively (P<0.001), and they barely increased with the saturated model (NRI increase, 0.017; P=0.12; IDI increase, 0.013; P=0.05; Figure 3A) .
For MCE, a total of 34 (22.7%) and 11 (7.3%) of 150 subjects with events were better and worse classified, respectively, when incorporating exercise information (Table 5) , which represents an NRI of 15.4% ( Figure 3B ). Addition of MPGS still improved the reclassification in 16% of people with event, but made it worst in 13.3% (net improvement, 2.7%; Table 6 and Figure 3B ). The net benefit of adding MPGS information was highest in people without MCE. In this case, MPGS information improved the rate of reclassification an additional 17.5%, and it worsened it in 8% of people without event (NRI, 9.5%). In global, the NRIs and IDIs for predicting MCE using clinical plus exercise test were 0.263 and 0.021, respectively (P<0.001), and they still increased in the saturated model (NRI increase, 0.122; P=0.011; IDI increase, 0.033; P<0.001; Figure 3B ). The statistical analyses were unchanged when considering the thresholds for defining low-, intermediate-, and high-risk categories as 1%, 1% to 3%, and >3% as described in the American College of Cardiology/ American Heart Association Stable Angina Guidelines (data not shown). 28 The analyses performed for estimating NRI and IDI index by bootstrapping were fairly similar (see Appendix in the online-only Data Supplement). 
C-Statisitc
Discussion
The present study shows that, beyond clinical data, information from both exercise test and MPGS is associated with major events and thus both are valid for prediction purposes. However, the impact of MPGS compared with exercise test to predict total death was scant as evaluated by the C-statistic, NRI, and IDI. For MCE, although classification of patients concerning their risk of future events is improved using the information from both techniques, the NRI was still higher with exercise test. Although the prognostic value of imaging on prediction of future events has been well established, 6, 9, 12, 13, 17 its incremental value compared with exercise test has not been properly assessed. Actually, in previous studies the stress information is limited to the type of stress (ie, exercise test versus pharmacological test) 10 or to the type of stress and the predicted maximum HR achieved, 13 which is an oversimplified view of the exercise test. In our study, the accurate quantification of METS and the millimeters of ST-segment deviation presumably enhanced the predictive ability of exercise stress testing for both end points. In addition, in the majority of studies, the incremental prognostic value of stress imaging has been defined as a significant gain based on χ 2 , Wald, or C-statistics when adding imaging information. 9, 11, 12 However, the demonstration of significant association does not necessarily imply clinical meaningfulness or improvement in model performance. 14 Therefore, some authors advocate the assessment of whether a new model more accurately stratifies patients into higher-or lower-risk categories and whether it improves sensitivity without sacrificing specificity as a way to complement the C-statistic analysis. 14, 29 This methodology, used in other scenarios, 30 had not been used to assess the incremental prognostic value of MPGS and stress testing over the clinical information so far.
Using this strategy, the addition of both sources of information (ie, exercise test and MPGS) into a global model did not add much to the stress information alone. Concerning MCE prediction, reclassification improvement with MPGS information was not as high as expected, although the addition of both sources of information improved the predictive ability of stress test alone. In any case, even in the best predicting model such as with the global saturated model to MCE prediction, the absolute accuracy is not high. For instance, among patients without events (n=5522; Table 4 ), a total of 2973 (53.8%) patients were incorrectly classified as moderate to high risk. This highlights the importance of considering the net improvement of a new model as comparing its performance with that of the prior old model. In the former example, a total of 3433 of 5522 patients without events (62.1%) were incorrectly classified as having a moderate-to-high risk with the prior model.
Among all available MPGS information, only the ejection fraction played a net role for total mortality prediction. This is partially in agreement with previous studies that identified ejection fraction and left ventricular volume as the main predictors of cardiac death. 31 However, in our study, ischemia was a relevant predictor of MCE. In this sense, although some authors warn against the use of composite end points to develop prognostic models, 31 we think that, when properly used, they may illustrate meaningful associations. 32 The present study was intended to assess whether the added prognostic value of MPGS on major outcomes justifies its use as a first-line study for prediction purposes. Our data do not support such use in patients who are able to perform an exercise test. However, as previously stated, useful information for prediction purposes is not necessarily useful for decisions in individual patients 31 concerning the selection of the best therapy. For instance, whereas ischemia has usually been a mediocre predictor of cardiac death, it has been shown to be helpful in identifying patients who may benefit from revascularization. 31 Thus, the small impact of MPGS on clinical management in a recent study 19 suggests that in the real world most common uses of this study could be well served by a simpler and cheaper stress test. In this sense, the total cost estimated for MPGS in the 5672 patients according to our institution fares is ≈2 166 704€ (≈$2 816 715) and with a simple exercise treadmill test, it would have been 510 480€ (≈$663 624). These extra 1 656 224€ spent in MPGS imaging have led to a total extra better 528 reclassifications for MCE (524 better reclassifications in people without event and 4 better reclassifications in people with event), or, in other words, each additional correct reclassification has cost ≈3137€ ($4078). For mortality prediction, the extra cost of every additional correct reclassification with MPGS is ≈9545€ ($12 408). Although this is not a cost-effectiveness study and thus these figures have to be cautiously interpreted, they approximately reflect the potential impact of a broad MPGS utilization for prediction purpose.
Limitations
We included patients with and without a history of coronary heart disease, which increases statistical power at the expense of greater heterogeneity. Thus, our findings may represent a mean estimate that could not be entirely extrapolated to specific populations, which would require further study.
Clinical outcomes were assessed with the use of a central administrative database that is clearly less precise than A EVENTS 12 clinical follow-up. For this reason, we opted for assessing the hard end point total mortality and the general end point MCE instead of the usually recommended and more specific end point cardiac mortality, 31 which carries a greater risk of misclassification. We used our scheme for quantifying ischemia (anterior, septal, apical, lateral, and inferior), which differs from the recommended 17-segment model. Although this approach could have limited the dynamic range of ischemic burden, it is unlikely that using the standard approach could have changed our findings in a relevant manner.
Because the selection process of variables was based on the best fitting of several exercise and MPGS variables, the statistical models may be overfit. Furthermore, as this is an observational study, selection bias and missing or unmeasured confounders are always possible. Finally, this study the experience of a single center, thus their findings may not be extrapolated to other scenarios. Total mortality across the 3 strata risk. Model using clinical plus exercise test plus SPECT information vs model using clinical plus exercise information. IDI indicates integrated discrimination improvement; NRI, net reclassification improvement; and SPECT, single photon emission computed tomography. Cardiovascular mortality or acute myocardial infarction across the 3 strata risk. Model using clinical plus exercise test information vs model using clinical information. AMI indicates acute myocardial infarction; IDI, integrated discrimination improvement; and NRI, net reclassification improvement. Cardiovascular mortality or acute myocardial infarction across the 3 strata risk. Model using clinical plus exercise test plus SPECT information vs model using clinical plus exercise information. AMI indicates acute myocardial infarction; IDI, integrated discrimination improvement; NRI, net reclassification improvement; and SPECT, single photon emission computed tomography.
